The AI Accelerator Grant under the Ovarian Cancer Research Alliance (OCRA) 2027 funding cycle is a highly competitive, globally open research funding opportunity designed to support innovative, data-driven, and artificial intelligence–powered approaches in ovarian cancer research. This grant aims to accelerate scientific discovery by integrating AI technologies into oncology research, improving early detection, treatment strategies, precision medicine, and overall patient outcomes.
Applications for the AI Accelerator Grant are submitted through the SmartSimple grant management system. Researchers worldwide are encouraged to participate, provided they meet institutional eligibility requirements.
This article provides a comprehensive breakdown of the grant cycle, deadlines, application process, eligibility criteria, review structure, and key opportunities available under OCRA’s AI Accelerator Grant program.
Overview of the AI Accelerator Grant Cycle (2027)
OCRA runs a structured annual funding cycle that includes a Letter of Intent (LOI) phase followed by a full proposal phase (by invitation only). The AI Accelerator Grant follows a clearly defined timeline:
Letter of Intent (LOI) Phase
- LOI Opens: Friday, May 8, 2026
- LOI Deadline: Tuesday, June 23, 2026 at 5:00 PM ET
- Status: Current active cycle stage
- Submission Platform: SmartSimple grant management system
- Note: Late submissions or extensions are strictly not permitted
Applicants must first submit a Letter of Intent outlining their proposed research, objectives, methodology, and relevance to AI in ovarian cancer research. Only selected applicants will be invited to submit full proposals.
Informational Webinar
OCRA will host a live informational webinar for prospective applicants:
- Date: Tuesday, May 19, 2026
- Time: 4:00 PM ET
- Purpose: To provide guidance on application requirements, eligibility, and evaluation criteria
- Recording: Available later on OCRA’s official website for those unable to attend
This session is highly recommended for applicants seeking clarity on expectations and proposal alignment.
Full Proposal Stage (By Invitation Only)
After rigorous peer review of LOIs:
- Full Proposal Invitation Notifications: August 2026
- Full Proposal Deadline: Thursday, September 10, 2026 at 5:00 PM ET
- Submission Requirement: Only invited applicants may proceed to this stage
Selected researchers will be asked to submit detailed proposals with expanded methodology, preliminary data, budget plans, and implementation strategies.
Funding Notification
- Expected Funding Decisions: Mid-November 2026
Successful applicants will receive formal notification and funding allocation details following final review by the Scientific Advisory Committee.
Review and Evaluation Process
OCRA ensures a rigorous, transparent, and confidential peer-review system. All submitted proposals are evaluated by a Scientific Advisory Committee.
Key aspects of the review process include:
- Scientific merit and innovation
- Feasibility and methodology
- Impact on ovarian cancer research
- Integration of artificial intelligence tools
- Strength of research design and data strategy
All review activities, including scoring, deliberations, and critiques, are strictly confidential. Reviewers are required to sign confidentiality and conflict-of-interest agreements.
Eligibility Criteria
The AI Accelerator Grant is open to a wide range of qualified research institutions globally. However, applicants must meet strict organizational requirements.
Eligible applicants include:
- Accredited non-profit universities and colleges
- Non-profit research hospitals
- Recognized non-profit scientific research institutions
Ineligible entities:
- For-profit companies
- Private consulting firms
- Non-profits not directly conducting research
Applicants must ensure that the host institution is responsible for the research execution.
Additional OCRA 2027 Grant Opportunities
Beyond the AI Accelerator Grant, OCRA offers several other funding mechanisms under its 2027 grant cycle, including:
- Collaborative Research Development Grant
- Collaborative Research Development Grant – AI
- Early Career Investigator Grant
- Mentored Investigator Grant
- Health Equity Research Grant
- Rivkin Pilot Grant
Each grant targets different stages of research development and investigator experience levels.
Application Platform
All applications must be submitted through the SmartSimple grant management system. Applicants are advised to register early, prepare documents in advance, and ensure compliance with formatting and submission guidelines.
Important Notes
- Extensions will not be granted under any circumstances
- Late submissions will not be accepted
- Only invited applicants proceed to full proposal stage
- LOIs are reviewed by expert scientific panels worldwide
- International applicants are encouraged to apply
Why This Grant Matters
The AI Accelerator Grant represents a strategic investment in the future of oncology research. By integrating artificial intelligence into ovarian cancer studies, this funding opportunity supports breakthroughs in:
- Early detection algorithms
- Predictive modeling for patient outcomes
- Drug discovery and treatment optimization
- Personalized medicine approaches
- Data-driven clinical decision-making
It is a critical opportunity for researchers working at the intersection of biomedical science and artificial intelligence.
Deadline
23rd June, 2026.
For more information on this opportunity,click here.
For more global opportunities,click here.
